Bausch + Lomb is assessing interest from potential buyers as a way around the roadblock, the FT wrote. The company had a ...

Press Release Nicox and Glaukos Sign Exclusive NCX 1728 Research and Global Licensing Option AgreementOption entitles Glaukos to exclusive global ...

Press Release Nicox Announces Approval of ZERVIATE in ChinaNicox’s partner, Ocumension Therapeutics, has received approval for ZERVIATE® for ...

The global ophthalmic eye drop market is poised for steady growth over the next decade. The market, which was valued at USD ...

Press Release Nicox Announces Approval of ZERVIATE in China Nicox's partner, Ocumension Therapeutics, has received approval for ZERVIATE® for ocular itching in China ZERVIATE® launch in China will ...

Investors are pouring money into corporate bonds, risk premiums are grinding tighter, and the Federal Reserve’s interest rate ...

The relation between the area of meibomian glands and dry eye symptoms was also assessed ... to displace the lacrimal gland anteriorly. One drop of dye, fluorescein sodium (Minims fluorescein sodium 2 ...

Shares of Bausch Health, Inc. BHC gained 14.7% in a week on reports of refinancing its debt to enable the impending sale of its eye care company, Bausch + Lomb BLCO. The industry declined 0.6% during ...

Bausch Health Cos. is working with Jefferies Financial Group to explore refinancing some of its debt to aid a long-planned ...

In its latest warning letter, FDA raised concern that the company was still producing eye drops with amniotic fluid, even ...